Royston Aaron
Insider CIK 1727703 · MNLO Director · AKRO Director · ELEV 10% owner · VTYX Director, 10% owner · ACHV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-07-27 | 2026-07-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-07-27 | 2026-07-29 | 16,700 | — | $0 | 16,700 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-07-27 | 2026-07-29 | 16,700 | — | $0 | 16,700 | SEC↗ |
| ACHV ACHIEVE LIFE SCIENCES, INC | A Award deriv | 2026-07-27 | 2026-07-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2022-06-09 | 2023-04-26 | 21,825 | — | $0 | 21,825 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | A Award deriv | 2022-06-09 | 2022-06-10 | 13,301 | — | $0 | 13,301 | SEC↗ |
| ELEV Elevation Oncology, Inc. | S Sale | 2022-05-25 | 2022-05-27 | 702,737 | $4.12 | $2.90M | 1,905,430 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | C Conversion deriv | 2021-10-25 | 2021-10-25 | 3,289,742 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | C Conversion deriv | 2021-10-25 | 2021-10-25 | 395,027 | — | $0 | 0 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | C Conversion | 2021-10-25 | 2021-10-25 | 3,684,769 | — | $0 | 3,684,769 | SEC↗ |
| VTYX Ventyx Biosciences, Inc. | P Buy | 2021-10-25 | 2021-10-25 | 312,500 | $16.00 | $5.00M | 3,997,269 | SEC↗ |
| ELEV Elevation Oncology, Inc. | C Conversion deriv | 2021-06-29 | 2021-07-01 | 8,380,034 | — | $0 | 0 | SEC↗ |
| ELEV Elevation Oncology, Inc. | P Buy | 2021-06-29 | 2021-07-01 | 625,000 | $16.00 | $10.00M | 2,608,167 | SEC↗ |
| ELEV Elevation Oncology, Inc. | C Conversion | 2021-06-29 | 2021-07-01 | 1,983,167 | — | $0 | 1,983,167 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-06-25 | 2019-08-08 | 22,500 | — | $0 | 22,500 | SEC↗ |
| MNLO Menlo Therapeutics Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 22,500 | — | $0 | 22,500 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-25 | 10,666,667 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion deriv | 2019-06-24 | 2019-06-25 | 722,737 | — | $0 | 0 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion | 2019-06-24 | 2019-06-25 | 3,469,759 | — | $0 | 3,719,759 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | P Buy | 2019-06-24 | 2019-06-25 | 250,000 | $16.00 | $4.00M | 250,000 | SEC↗ |
| AKRO Akero Therapeutics, Inc. | C Conversion | 2019-06-24 | 2019-06-25 | 235,099 | — | $0 | 3,954,858 | SEC↗ |